Physician profile
Benjamin Lebwohl
NPI 1386680064
$20,824.38
in general payments reported to CMS, 2019-2025
5 companies · $14K in 2025
The $14K reported for 2025 was more than what 94% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,905 · 2022: $12.70 · 2023: $162 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Travel and Lodging: $1,457 · Food and Beverage: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,236.50 |
| Travel and Lodging | $1,456.53 |
| Food and Beverage | $213.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $11,512.96 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $7,066.68 | 2019-2023 | |
| Chugai Pharmaceutical Co., LTD. | $2,209.15 | 2025 | |
| Pentax of America, INC. | $22.89 | 2025 | Pentax Medical, Inspira, C2 Cryoballoon Focal Controller |
| E.R. Squibb & Sons, L.L.C. | $12.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Lebwohl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.